US Stock MarketDetailed Quotes

Kairos Pharma (KAPA)

Watchlist
  • 0.4460
  • +0.0059+1.34%
Close Jun 16 16:00 ET
  • 0.4370
  • -0.0090-2.02%
Post 19:43 ET
9.55MMarket Cap-1.49P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Kairos Pharma (KAPA) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
33.49%1.69M
137.81%5.57M
-2.14%1.42M
274.67%1.44M
555.86%1.46M
341.11%1.27M
36.70%2.34M
32.78%1.45M
33.45%383K
4.72%222K
Selling and administrative expenses
31.79%966K
85.25%3.28M
-32.17%837K
139.21%787K
673.11%920K
793.90%733K
20.18%1.77M
18.43%1.23M
53.74%329K
-12.50%119K
-General and administrative expense
31.79%966K
85.25%3.28M
-32.17%837K
139.21%787K
673.11%920K
793.90%733K
20.18%1.77M
18.43%1.23M
53.74%329K
-12.50%119K
Research and development costs
38.74%684K
415.70%2.14M
212.79%538K
4,242.86%608K
687.30%496K
198.79%493K
404.88%414K
2,357.14%172K
-57.58%14K
75.00%63K
Depreciation amortization depletion
0.00%40K
0.00%160K
0.00%40K
0.00%40K
0.00%40K
0.00%40K
0.00%160K
0.00%40K
0.00%40K
0.00%40K
-Depreciation and amortization
0.00%40K
0.00%160K
0.00%40K
0.00%40K
0.00%40K
0.00%40K
0.00%160K
0.00%40K
0.00%40K
0.00%40K
Operating profit
-33.49%-1.69M
-137.81%-5.57M
2.14%-1.42M
-274.67%-1.44M
-555.86%-1.46M
-341.11%-1.27M
-36.70%-2.34M
-32.78%-1.45M
-33.45%-383K
-4.72%-222K
Net non-operating interest income expense
800.00%36K
114.55%125K
137.59%50K
105.57%37K
209.68%34K
111.11%4K
-776.53%-859K
-358.62%-133K
-2,556.00%-664K
-29.17%-31K
Non-operating interest income
800.00%36K
--125K
--50K
--37K
--34K
--4K
--0
--0
--0
--0
Non-operating interest expense
----
--0
--0
--0
--0
--0
92.86%189K
--0
408.00%127K
29.17%31K
Total other finance cost
----
----
----
----
----
----
--670K
--133K
--537K
----
Other net income (expense)
599K
Special income (charges)
----
--0
----
----
----
----
--599K
----
----
----
-Less:Other special charges
----
----
----
----
----
----
---599K
----
----
----
Income before tax
-31.06%-1.65M
-109.26%-5.45M
-39.29%-1.37M
-33.52%-1.4M
-462.06%-1.42M
-290.71%-1.26M
-43.65%-2.6M
12.34%-980K
-235.58%-1.05M
-7.20%-253K
Income tax
Net income
-31.06%-1.65M
-109.26%-5.45M
-39.29%-1.37M
-33.52%-1.4M
-462.06%-1.42M
-290.71%-1.26M
-43.65%-2.6M
12.34%-980K
-235.58%-1.05M
-7.20%-253K
Net income continuous Operations
-31.06%-1.65M
-109.26%-5.45M
-39.29%-1.37M
-33.52%-1.4M
-462.06%-1.42M
-290.71%-1.26M
-43.65%-2.6M
12.34%-980K
-235.58%-1.05M
-7.20%-253K
Minority interest income
Net income attributable to the parent company
-31.06%-1.65M
-109.26%-5.45M
-39.29%-1.37M
-33.52%-1.4M
-462.06%-1.42M
-290.71%-1.26M
-43.65%-2.6M
12.34%-980K
-235.58%-1.05M
-7.20%-253K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-31.06%-1.65M
-109.26%-5.45M
-39.29%-1.37M
-33.52%-1.4M
-462.06%-1.42M
-290.71%-1.26M
-43.65%-2.6M
12.34%-980K
-235.58%-1.05M
-7.20%-253K
Basic earnings per share
0.00%-0.08
-30.43%-0.3
12.50%-0.07
30.00%-0.07
-306.07%-0.08
-177.79%-0.08
-42.36%-0.23
19.74%-0.08
-259.48%-0.1
1.50%-0.0197
Diluted earnings per share
0.00%-0.08
-30.43%-0.3
12.50%-0.07
30.00%-0.07
-306.07%-0.08
-177.79%-0.08
-42.36%-0.23
19.74%-0.08
-259.48%-0.1
1.50%-0.0197
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 33.49%1.69M137.81%5.57M-2.14%1.42M274.67%1.44M555.86%1.46M341.11%1.27M36.70%2.34M32.78%1.45M33.45%383K4.72%222K
Selling and administrative expenses 31.79%966K85.25%3.28M-32.17%837K139.21%787K673.11%920K793.90%733K20.18%1.77M18.43%1.23M53.74%329K-12.50%119K
-General and administrative expense 31.79%966K85.25%3.28M-32.17%837K139.21%787K673.11%920K793.90%733K20.18%1.77M18.43%1.23M53.74%329K-12.50%119K
Research and development costs 38.74%684K415.70%2.14M212.79%538K4,242.86%608K687.30%496K198.79%493K404.88%414K2,357.14%172K-57.58%14K75.00%63K
Depreciation amortization depletion 0.00%40K0.00%160K0.00%40K0.00%40K0.00%40K0.00%40K0.00%160K0.00%40K0.00%40K0.00%40K
-Depreciation and amortization 0.00%40K0.00%160K0.00%40K0.00%40K0.00%40K0.00%40K0.00%160K0.00%40K0.00%40K0.00%40K
Operating profit -33.49%-1.69M-137.81%-5.57M2.14%-1.42M-274.67%-1.44M-555.86%-1.46M-341.11%-1.27M-36.70%-2.34M-32.78%-1.45M-33.45%-383K-4.72%-222K
Net non-operating interest income expense 800.00%36K114.55%125K137.59%50K105.57%37K209.68%34K111.11%4K-776.53%-859K-358.62%-133K-2,556.00%-664K-29.17%-31K
Non-operating interest income 800.00%36K--125K--50K--37K--34K--4K--0--0--0--0
Non-operating interest expense ------0--0--0--0--092.86%189K--0408.00%127K29.17%31K
Total other finance cost --------------------------670K--133K--537K----
Other net income (expense) 599K
Special income (charges) ------0------------------599K------------
-Less:Other special charges ---------------------------599K------------
Income before tax -31.06%-1.65M-109.26%-5.45M-39.29%-1.37M-33.52%-1.4M-462.06%-1.42M-290.71%-1.26M-43.65%-2.6M12.34%-980K-235.58%-1.05M-7.20%-253K
Income tax
Net income -31.06%-1.65M-109.26%-5.45M-39.29%-1.37M-33.52%-1.4M-462.06%-1.42M-290.71%-1.26M-43.65%-2.6M12.34%-980K-235.58%-1.05M-7.20%-253K
Net income continuous Operations -31.06%-1.65M-109.26%-5.45M-39.29%-1.37M-33.52%-1.4M-462.06%-1.42M-290.71%-1.26M-43.65%-2.6M12.34%-980K-235.58%-1.05M-7.20%-253K
Minority interest income
Net income attributable to the parent company -31.06%-1.65M-109.26%-5.45M-39.29%-1.37M-33.52%-1.4M-462.06%-1.42M-290.71%-1.26M-43.65%-2.6M12.34%-980K-235.58%-1.05M-7.20%-253K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -31.06%-1.65M-109.26%-5.45M-39.29%-1.37M-33.52%-1.4M-462.06%-1.42M-290.71%-1.26M-43.65%-2.6M12.34%-980K-235.58%-1.05M-7.20%-253K
Basic earnings per share 0.00%-0.08-30.43%-0.312.50%-0.0730.00%-0.07-306.07%-0.08-177.79%-0.08-42.36%-0.2319.74%-0.08-259.48%-0.11.50%-0.0197
Diluted earnings per share 0.00%-0.08-30.43%-0.312.50%-0.0730.00%-0.07-306.07%-0.08-177.79%-0.08-42.36%-0.2319.74%-0.08-259.48%-0.11.50%-0.0197
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +30.23%
Sample Name
Sample Code
 +18.68%
Sample Name
Sample Code
 -10.52%
4
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
-10.81%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
-13.32%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +8.75%
Sample Name
Sample Code
 +6.49%
Sample Name
Sample Code
 +5.83%
4
Chagee Holdings
CHA
+5.69%
5
Futu Holdings Ltd
FUTU
+5.15%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On Tuesday, Trump stated that the United States and Iran had successfully signed a memorandum of understanding online, and that their negoti Show More
美伊和平曙光初現！全球市場「拆彈式狂歡」：誰在帶頭衝鋒，升势還能跑多遠？
After the U.S.-Iran memorandum of understanding, crude oil dropped 5%, and my first instinct was to check calls on airline stocks

- No more -